Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium Sulphate with Low Dose Rocuronium in Laryngeal Tumor Surgery
NCT04510337Completed
- Sponsor
- National Cancer Institute
- Start
- Apr 2018
- Primary completion
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of magnesium sulfate in laryngeal cancer (2 arms), sponsored by National Cancer Institute. Primary endpoints: Onset of muscle relaxant at 90 minutes and Duration of muscle relaxant at 90 minutes. Started Apr 2018; status: completed.
02
Drugs
magnesium sulfate
03
Conditions
laryngeal cancer
Beyond the preview
Go deeper on NCT04510337.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04510337.